Literature DB >> 1515593

Chol-1 is a cholinergic marker in the human central nervous system.

V P Whittaker1, E A Derrington, E Borroni.   

Abstract

The cholinergic-specific gangliosides Chol-1 alpha and beta were detected in human brain and spinal cord by immune staining of thin-layer chromatography (TLC) plates on which ganglioside extracts had been separated. The colocalization of choline acetyltransferase (ChAT) and the Chol-1 antigens in ventral horn motoneurons was demonstrated immunocytochemically. In analytical studies, Chol-1 was found to be more concentrated in dorsal cord than ventral but the reverse was true of ChAT. This difference was explained by differences in the subcellular location of the two markers. Within each region of the thoracic cord the levels of ChAT and Chol-1 in different cords showed covariance. The expected fall of ChAT and Chol-1 in amyotrophic lateral sclerosis (ALS) cords was not seen and possible reasons for this are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1515593     DOI: 10.1097/00001756-199204000-00013

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.

Authors:  Toshio Ariga; Makoto Yanagisawa; Chandramohan Wakade; Susumu Ando; Jerry J Buccafusco; Michael P McDonald; Robert K Yu
Journal:  ASN Neuro       Date:  2010-10-04       Impact factor: 4.146

Review 2.  The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.

Authors:  Toshio Ariga
Journal:  Mol Neurobiol       Date:  2017-01       Impact factor: 5.590

Review 3.  Cholinergic-specific glycoconjugates.

Authors:  V P Whittaker; S Kelić
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

4.  Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1aα.

Authors:  Toshio Ariga; Yutaka Itokazu; Michael P McDonald; Yoshio Hirabayashi; Susumu Ando; Robert K Yu
Journal:  ASN Neuro       Date:  2013-05-30       Impact factor: 4.146

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.